Content uploaded by Amanda E. Ng
Author content
All content in this area was uploaded by Amanda E. Ng on Jul 23, 2024
Content may be subject to copyright.
NCHS Data Brief ■ No. 473 ■ July 2023
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics
Diagnosed Developmental Disabilities in
Children Aged 3–17 Years: United States, 2019–2021
Benjamin Zablotsky, Ph.D., Amanda E. Ng, M.P.H., Lindsey I. Black, M.P.H., and
Stephen J. Blumberg, Ph.D.
Key findings
Data from the National
Health Interview Survey
●During 2019–2021,
the prevalence of any
diagnosed developmental
disability in children aged
3–17 years increased from
7.40% to 8.56%.
●The prevalence of any
developmental disability was
lowest in non-Hispanic Asian
children compared with other
race and Hispanic-origin groups.
●The prevalence of
intellectual disability increased
with age, while the prevalence
of other developmental delay
decreased with age.
●Boys (4.66%) were more
than three times as likely as
girls (1.50%) to be diagnosed
with autism spectrum disorder.
Developmental disabilities are common in children in the United States,
and the prevalence has increased in recent years (1). Timely estimates are
necessary to assess the adequacy of services and interventions that children
with developmental disabilities typically need (2). This report provides updated
prevalence estimates for diagnosed autism spectrum disorder, intellectual
disability, and other developmental delay among children aged 3–17 years
from the 2019–2021 National Health Interview Survey (NHIS), with
differences in prevalence examined between years and by sex, age group, and
race and Hispanic origin. Estimates are also presented for any developmental
disability, defined as having had one or more of these three diagnoses.
The prevalence of any developmental disability, including
other developmental delay, increased from 2019 to 2021.
NCHS reports can be downloaded from: https://www.cdc.gov/nchs/products/index.htm.
Percent
Figure 1. Prevalence of children aged 3–17 years ever diagnosed with selected developmental
disabilities, by year: United States, 2019–2021
202120202019
1
Linear increase from 2019 to 2021 is significant (p < 0.05).
NOTES: Developmental disability includes autism spectrum disorder, intellectual disability, and any other developmental delay.
As children could be diagnosed with multiple developmental disabilities, “any developmental disability” is not the combined sum of
intellectual disability, autism spectrum disorder, and other developmental delay. Estimates are based on household interviews of a
sample of the U.S. civilian noninstitutionalized population. Access data table for Figure 1 at:
https://www.cdc.gov/nchs/data/
databriefs/db473-tables.pdf#1
.
SOURCE: National Center for Health Statistics, National Health Interview Survey, 2019–2021.
0
2
4
6
8
10
Other
developmental
delay1
Autism spectrum
disorder
Intellectual
disability
Any developmental
disability1
7.40
8.34 8.56
1.70 2.20 1.65
2.79 3.49 3.05
5.08
5.86 6.06
NCHS Data Brief ■ No. 473 ■ July 2023
■ 2 ■
●During 2019–2021, the prevalence of any diagnosed developmental disability in children
aged 3–17 years increased from 7.40% in 2019 to 8.56% in 2021 (Figure 1).
●No significant change in the prevalence of diagnosed intellectual disability was observed
during 2019–2021 (1.70% in 2019, 2.20% in 2020, and 1.65% in 2021).
●No significant change in the prevalence of diagnosed autism spectrum disorder was
observed during 2019–2021 (2.79% in 2019, 3.49% in 2020, and 3.05% in 2021).
●The prevalence of diagnosed other developmental delay increased from 5.08% in 2019 to
6.06% in 2021.
The prevalence of any developmental disability varied by sex and race and
Hispanic origin but not age group.
●During 2019–2021, the prevalence of any developmental disability was higher in boys
(10.76%) than girls (5.31%) (Figure 2).
●The prevalence of any developmental disability was similar across age groups: 8.42% in
children aged 3–7, 8.05% in children aged 8–12, and 7.84% in children aged 13–17.
Figure 2. Prevalence of children aged 3–17 years ever diagnosed with any developmental disability, by sex, age, and
race and Hispanic origin: United States, 2019–2021
1
Significantly different from girls (p < 0.05).
2
Significantly different from Asian, non-Hispanic children (p < 0.05).
3
Children of Hispanic origin may be of any race.
NOTES: Developmental disability includes autism spectrum disorder, intellectual disability, and any other developmental delay. Estimates are based on household
interviews of a sample of the U.S. civilian noninstitutionalized population. Access data table for Figure 2 at:
https://www.cdc.gov/nchs/data/databriefs/
db473-tables.pdf#2
.
SOURCE: National Center for Health Statistics, National Health Interview Survey, 2019–2021.
Percent
0 2 4 6 8 10 12
Hispanic3
White, non-Hispanic
Black, non-Hispanic
Asian, non-Hispanic
13–17
8–12
3–7
Girls
Boys
Total
27.40
28.42
29.07
4.85
7.84
8.05
8.42
5.31
110.76
8.10
NCHS Data Brief ■ No. 473 ■ July 2023
■ 3 ■
●Non-Hispanic Asian children (subsequently, Asian) (4.85%) were less likely to have any
developmental disability compared with Hispanic (7.40%), non-Hispanic Black (subsequently,
Black) (9.07%), and non-Hispanic White (subsequently, White) (8.42%) children.
●The observed differences in the prevalence of any developmental disability between
Hispanic and Black children and Hispanic and White children were not significant.
The prevalence of intellectual disability varied by sex, age group, and race
and Hispanic origin.
●During 2019–2021, the prevalence of diagnosed intellectual disability was higher in boys
(2.31%) than girls (1.37%) (Figure 3).
●The prevalence of intellectual disability increased with age, from 1.39% for children aged
3–7 years to 2.35% for children aged 13–17 years.
●Black children (2.82%) were more likely to be diagnosed with an intellectual disability than
Hispanic (1.77%), White (1.76%), and Asian (0.72%) children.
●Compared with other race and Hispanic-origin groups, Asian children were the least likely
to be diagnosed with an intellectual disability.
Figure 3. Prevalence of children aged 3–17 years ever diagnosed with intellectual disability, by sex, age, and
race and Hispanic origin: United States, 2019–2021
1
Significantly different from girls (p < 0.05).
2
Significant linear trend by age group (p < 0.05).
3
Significantly different from Asian, non-Hispanic children (p < 0.05).
4
Significantly different from Black, non-Hispanic children (p < 0.05).
5
Children of Hispanic origin may be of any race.
NOTES: Estimates are based on household interviews of a sample of the U.S. civilian noninstitutionalized population. Access data table for Figure 3 at:
https://www.cdc.gov/nchs/data/databriefs/db473-tables.pdf#3
.
SOURCE: National Center for Health Statistics, National Health Interview Survey, 2019–2021.
Percent
Hispanic
5
White, non-Hispanic
Black, non-Hispanic
Asian, non-Hispanic
13–17
8–12
3–7
Girls
Boys
Total
3,4
1.77
3,4
1.76
3
2.82
0.72
1.79
2.35
2
1.39
1.37
1
2.31
1.85
0123
NCHS Data Brief ■ No. 473 ■ July 2023
■ 4 ■
The prevalence of autism spectrum disorder varied by sex and age group.
●During 2019–2021, the prevalence of autism spectrum disorder was higher in boys (4.66%)
than girls (1.50%) (Figure 4).
●Children aged 3–7 years (2.62%) were less likely to have been diagnosed with autism
spectrum disorder than children aged 8–12 years (3.36%) and 13–17 years (3.35%).
●While the prevalence of autism spectrum disorder was highest in Black children (3.56%), a
significant difference was not observed between any of the race and Hispanic-origin groups.
Figure 4. Prevalence of children aged 3–17 years ever diagnosed with autism spectrum disorder, by sex, age, and
race and Hispanic origin: United States, 2019–2021
1
Significantly different from girls (p < 0.05).
2
Significant linear trend by age group (p < 0.05).
3
Children of Hispanic origin may be of any race.
NOTES: Estimates are based on household interviews of a sample of the U.S. civilian noninstitutionalized population. Access data table for Figure 4 at:
https://www.cdc.gov/nchs/data/databriefs/db473-tables.pdf#4
.
SOURCE: National Center for Health Statistics, National Health Interview Survey, 2019–2021.
Percent
Hispanic3
White, non-Hispanic
Black, non-Hispanic
Asian, non-Hispanic
13–17
8–12
3–7
Girls
Boys
Total
2.96
3.06
3.56
2.87
3.35
3.36
22.62
1.50
14.66
3.11
012345
NCHS Data Brief ■ No. 473 ■ July 2023
■ 5 ■
The prevalence of developmental delay other than autism spectrum
disorder or intellectual disability varied by sex, age group, and race and
Hispanic origin.
●During 2019–2021, the prevalence of any other developmental delay was higher in boys
(7.31%) than girls (3.94%) (Figure 5).
●The prevalence of any other developmental delay decreased with age, from 6.58% for
children aged 3–7 years to 4.89% for children aged 13–17 years.
●Asian children (2.53%) were less likely to have any other developmental delay compared
with Hispanic (5.13%), Black (6.43%), and White (6.00%) children.
●The observed differences in the prevalence of any other developmental delay between
Hispanic and Black children and Hispanic and White children were not significant.
Figure 5. Prevalence of children aged 3–17 years ever diagnosed with other developmental delay, by sex, age, and
race and Hispanic origin: United States, 2019–2021
1
Significantly different from girls (p < 0.05).
2
Significant linear trend by age group (p < 0.05).
3
Significantly different from Asian, non-Hispanic children (p < 0.05).
4
Children of Hispanic origin may be of any race.
NOTES: Estimates are based on household interviews of a sample of the U.S. civilian noninstitutionalized population. Access data table for Figure 5 at:
https://www.cdc.gov/nchs/data/databriefs/db473-tables.pdf#5
.
SOURCE: National Center for Health Statistics, National Health Interview Survey, 2019–2021.
02468
Percent
Hispanic4
White, non-Hispanic
Black, non-Hispanic
Asian, non-Hispanic
13–17
8–12
3–7
Girls
Boys
Total
35.13
36.00
36.43
2.53
4.89
5.56
26.58
3.94
17.31
5.67
NCHS Data Brief ■ No. 473 ■ July 2023
■ 6 ■
Summary
During 2019–2021, a significant increase in the prevalence of any diagnosed developmental
disability was observed. However, no significant change in the prevalence of diagnosed autism
spectrum disorder or intellectual disability was observed over the same period. The increase in
the prevalence of any developmental disability was largely the result of the significant increase in
prevalence of any other developmental delay.
Estimates presented in this report are the first on developmental disabilities from NHIS since
the survey was redesigned in 2019. While the prevalence reported in this report was higher for
each selected condition than in a previous report from NHIS (3) with estimates from 2014–2016,
these estimates may not be comparable with pre-redesign estimates. Boys were more likely to
be diagnosed with a developmental disability than girls, younger children were less likely to be
diagnosed with intellectual disability, and older children were less likely to be diagnosed with a
developmental delay. This report did not find Black and Hispanic children to be more likely to be
diagnosed with autism spectrum disorder compared with White children, unlike recent reports (4).
Definitions
Diagnosed developmental disabilities: Children were considered to have a developmental
disability if they were diagnosed with one or more of the three selected developmental
disabilities:
●Autism spectrum disorder: Based on a “yes” response to the survey question, “Has a
doctor or other health professional ever told you that [sample child] had autism, Asperger’s
disorder, pervasive developmental disorder, or autism spectrum disorder?” Children
diagnosed with autism spectrum disorder could also be diagnosed with intellectual
disability.
●Intellectual disability: Based on a “yes” response to the survey question, “Has a doctor or
other health professional ever told you that [sample child] had an intellectual disability, also
known as mental retardation?” Children diagnosed with intellectual disability could also be
diagnosed with autism spectrum disorder.
●Other developmental delay: Based on a “yes” response to the survey question, “Has
a doctor or other health professional ever told you that [sample child] had any other
developmental delay?” Parents who affirmed that their child had autism spectrum disorder
or intellectual disability were asked to exclude those conditions when asked about any other
developmental delay. Children who were diagnosed with either or both autism spectrum
disorder and intellectual disability and had a “yes” response to this survey question were
considered to have been diagnosed with both or all three conditions.
Race and Hispanic origin: Categories shown for non-Hispanic children are for those who selected
only one racial group; respondents had the option to select more than one racial group. Children
categorized as Hispanic may be of any race or combination of races. Estimates for non-Hispanic
children of races other than White only, Black only, or Asian only are not shown but are included
in total estimates. Analyses were limited to the race and Hispanic-origin groups for which data
NCHS Data Brief ■ No. 473 ■ July 2023
■ 7 ■
were reliable and sufficiently powered for group comparisons based on National Center for
Health Statistics presentation standards (5).
Data source and methods
Data from the 2019–2021 NHIS were used for this analysis. NHIS is a nationally representative
household survey of the U.S. civilian noninstitutionalized population. It is conducted
continuously throughout the year by the National Center for Health Statistics. Interviews are
typically conducted in respondents’ homes, but follow-ups to complete interviews may be
conducted over the telephone. Because of the COVID-19 pandemic, interviewing procedures
were disrupted, and 68.0% of 2020 and 61.4% of 2021 Sample Child interviews were conducted
at least partially by telephone (6,7). In 2019, 31.7% of Sample Child interviews were conducted
at least partially by telephone (8). For more information about NHIS, visit https://www.cdc.gov/
nchs/nhis.htm. The NHIS questionnaire was redesigned in 2019, which may impact the ability
to compare estimates from this report with previous years. For more information on the NHIS
redesign, visit https://www.cdc.gov/nchs/nhis/2019_quest_redesign.htm.
Point estimates and the corresponding confidence intervals were calculated using SAS-callable
SUDAAN software (9). All estimates are based on parent or guardian report and meet National
Center for Health Statistics data presentation standards for proportions (5). Estimates are presented
at two decimal places to allow comparability with reports from the Autism and Developmental
Disabilities Monitoring Network (4) and previous National Center for Health Statistics reports
(3). Differences between percentages were evaluated using two-sided significance tests at the 0.05
level via logistic regression. Linear and quadratic trends by age group were evaluated using
two-sided significance tests at the 0.05 level.
About the authors
Benjamin Zablotsky, Amanda E. Ng, Lindsey I. Black, and Stephen J. Blumberg are with the
National Center for Health Statistics, Division of Health Interview Statistics.
References
1. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Danielson ML, Bitsko RH, et al.
Prevalence and trends of developmental disabilities among children in the United States:
2009–2017. Pediatrics 144(4):e20190811. 2019.
2. Cogswell ME, Coil E, Tian LH, Tinker SC, Ryerson AB, Maenner MJ, et al. Health needs
and use of services among children with developmental disabilities—United States, 2014–2018.
MMWR Morb Mortal Wkly Rep 71(12):453–8. 2022.
3. Zablotsky B, Black LI, Blumberg SJ. Estimated prevalence of children with diagnosed
developmental disabilities in the United States, 2014–2016. NCHS Data Brief, no 291.
Hyattsville, MD: National Center for Health Statistics. 2017.
4. Maenner MJ, Warren Z, Williams AR, Amoakohene E, Bakian AV, Bilder DA, et al.
Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism
and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020. MMWR
Surveill Summ 72(2):1–14. 2023.
NCHS Data Brief ■ No. 473 ■ July 2023
5. Parker JD, Talih M, Malec DJ, Beresovsky V, Carroll M, Gonzalez JF
Jr, et al. National Center for Health Statistics data presentation standards for
proportions. National Center for Health Statistics. Vital Health Stat 2(175).
2017.
6. National Center for Health Statistics. National Health Interview Survey,
2020 survey description. 2021. Available from: https://ftp.cdc.gov/pub/
Health_Statistics/NCHS/Dataset_Documentation/NHIS/2020/srvydesc-508.pdf.
7. National Center for Health Statistics. National Health Interview Survey,
2021 survey description. 2022. Available from: https://ftp.cdc.gov/pub/
Health_Statistics/NCHS/Dataset_Documentation/NHIS/2021/srvydesc-508.pdf.
8. National Center for Health Statistics. National Health Interview Survey,
2019 survey description. 2020. Available from: https://ftp.cdc.gov/pub/
Health_Statistics/NCHS/Dataset_Documentation/NHIS/2019/srvydesc-508.pdf.
9. RTI International. SUDAAN (Release 11.0.3) [computer software]. 2018.
Keywords: autism spectrum disorder • intellectual disability • other
developmental delay • developmental disability • National Health Interview
Survey (NHIS)
Suggested citation
Zablotsky B, Ng AE, Black LI, Blumberg SJ.
Diagnosed developmental disabilities in children
aged 3–17 years: United States, 2019–2021.
NCHS Data Brief, no 473. Hyattsville, MD:
National Center for Health Statistics. 2023. DOI:
https://dx.doi.org/10.15620/cdc:129520.
Copyright information
All material appearing in this report is in the
public domain and may be reproduced or copied
without permission; citation as to source,
however, is appreciated.
National Center for Health
Statistics
Brian C. Moyer, Ph.D., Director
Amy M. Branum, Ph.D., Associate Director for
Science
Division of Health Interview Statistics
Stephen J. Blumberg, Ph.D., Director
Anjel Vahratian, Ph.D., M.P.H., Associate
Director for Science
For e-mail updates on NCHS publication
releases, subscribe online at:
https://www.cdc.gov/nchs/email-updates.htm.
For questions or general information
about NCHS:
Tel: 1–800–CDC–INFO (1–800–232–4636)
TTY: 1–888–232–6348
Internet: https://www.cdc.gov/nchs
Online request form: https://www.cdc.gov/info
ISSN 1941–4927 Print ed.
ISSN 1941–4935 Online ed.
CS340957
U.S. DEPARTMENT OF
HEALTH & HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics
3311 Toledo Road, Room 4551, MS P08
Hyattsville, MD 20782–2064
OFFICIAL BUSINESS
PENALTY FOR PRIVATE USE, $300
For more NCHS Data Briefs, visit:
https://www.cdc.gov/nchs/products/databriefs.htm.
FIRST CLASS MAIL
POSTAGE & FEES PAID
CDC/NCHS
PERMIT NO. G-284